Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TANDKLINIKKEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%   Bankruptcy risk   2.2% 2.4% 2.2% 3.3% 1.9% 3.0% 13.9% 13.6%   Credit score (0-100)   67 63 65 54 69 58 16 17   Credit rating   BBB BBB BBB BBB A BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,710 1,408 1,641 1,493 2,082 1,585 0.0 0.0   EBITDA   706 75.6 173 21.1 695 60.9 0.0 0.0   EBIT   700 47.0 130 -21.7 653 23.6 0.0 0.0   Pre-tax profit (PTP)   697.4 41.2 110.0 -44.9 643.5 13.9 0.0 0.0   Net earnings   543.5 31.5 85.3 -36.8 500.5 10.3 0.0 0.0   Pre-tax profit without non-rec. items   697 41.2 110 -44.9 643 13.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   78.1 180 137 94.3 51.6 14.3 0.0 0.0   Shareholders equity total   619 450 211 174 674 485 360 360   Interest-bearing liabilities   0.0 110 234 206 95.4 305 0.0 0.0   Balance sheet total (assets)   869 882 734 589 1,177 953 360 360   Net Debt   -311 -419 -238 -132 -846 -490 -360 -360     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,710 1,408 1,641 1,493 2,082 1,585 0.0 0.0   Gross profit growth   239.2% -17.7% 16.6% -9.0% 39.5% -23.9% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   869 882 734 589 1,177 953 360 360   Balance sheet change%   228.6% 1.5% -16.8% -19.7% 99.8% -19.0% -62.3% 0.0%   Added value   706.1 75.6 172.6 21.1 695.4 60.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   72 73 -86 -86 -86 -75 -14 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   40.9% 3.3% 7.9% -1.5% 31.3% 1.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   123.9% 5.4% 16.1% -3.3% 73.9% 2.2% 0.0% 0.0%   ROI %   198.6% 7.5% 23.0% -4.9% 113.5% 3.0% 0.0% 0.0%   ROE %   156.5% 5.9% 25.8% -19.2% 118.0% 1.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   71.3% 51.1% 28.7% 29.5% 57.3% 50.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -44.0% -554.5% -137.7% -623.4% -121.6% -804.4% 0.0% 0.0%   Gearing %   0.0% 24.3% 111.0% 118.7% 14.2% 62.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 10.7% 11.5% 10.6% 6.0% 4.8% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   3.2 1.8 1.2 1.1 3.0 1.9 0.0 0.0   Current Ratio   3.2 1.8 1.2 1.1 3.0 1.9 0.0 0.0   Cash and cash equivalent   310.6 528.6 471.4 337.9 941.0 794.5 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   520.2 301.4 103.8 46.5 728.4 441.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   353 38 86 11 348 30 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   353 38 86 11 348 30 0 0   EBIT / employee   350 24 65 -11 326 12 0 0   Net earnings / employee   272 16 43 -18 250 5 0 0